MPE has developed a series of Q&As for patients and patient advocates, covering treatment updates and relevant advocacy topics. Check the following Q&As on access and policy. To check all available Q&As click here.
What we do
- Member and patient community programmes
- MPE Masterclass
- Scholarship programme
- Myeloma CABs
- MPE Myeloma and AL amyloidosis Community Taskforce
- Advocate Development Programme
- European Young Myeloma Patients Group
- Reasonable Agreements between Patient Advocates and Pharmaceutical Companies (RAPP)
- Research
- Access and Policy
- Educational Resources